Regulatory policies play a crucial role in shaping market competition. Agencies like the FDA in the United States and the EMA in Europe set the standards for drug approval, which can either expedite or delay the entry of new treatments into the market. Stringent regulatory requirements ensure the safety and efficacy of new drugs but can also pose significant barriers to entry, particularly for smaller companies with limited resources.
